Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study-Reference-Cited by-同舟云学术

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Published:2012-05 Issue:5 Volume:11 Page:420-428
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Devonshire Virginia,Havrdova Eva,Radue Ernst Wilhelm,O'Connor Paul,Zhang-Auberson Lixin,Agoropoulou Catherine,Häring Dieter Adrian,Francis Gordon,Kappos Ludwig

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference15 articles.

1. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis;Kappos;N Engl J Med,2010

2. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis;Cohen;N Engl J Med,2010

3. Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results;Comi;Mult Scler,2010

4. Oral fingolimod (FTY720) for relapsing multiple sclerosis;Kappos;N Engl J Med,2006

5. Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis;Portaccio;Eur Neurol,2008

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populations;Multiple Sclerosis Journal;2024-09-08

2. Real-world effectiveness of disease-modifying therapies in older adults with multiple sclerosis;Journal of Medicine, Surgery, and Public Health;2024-08

3. As time goes by: Treatment challenges in elderly people with multiple sclerosis;Journal of Neuroimmunology;2024-06

4. Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry;Journal of the Neurological Sciences;2024-06

5. Management of multiple sclerosis in older adults: review of current evidence and future perspectives;Journal of Neurology;2024-04-30